Device Medical Device

(6554) Periph Vasc Undiv

Payments companies reported to CMS as associated with (6554) Periph Vasc Undiv. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$189Kassociated payments (2023-2025)
126clinicians with associated payments
2companies reporting

By year

2023 $189K
2024 $17.93

Payments reported as associated with (6554) Periph Vasc Undiv, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular Surgery $95K
Vascular & Interventional Radiology $45K
Interventional Cardiology $38K
Cardiovascular Disease $8,024
Surgery $1,271
Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,038

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (6554) Periph Vasc Undiv

These are the largest totals companies reported as associated with (6554) Periph Vasc Undiv. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Joseph Ricotta Delray Beach, FL Vascular Surgery $26,325.00
Steven Elias Englewood, NJ Vascular Surgery $20,726.00
Edward Arous Worcester, MA Vascular Surgery $13,218.62
Kush Desai Chicago, IL Vascular & Interventional Radiology $10,500.00
Paul Gagne Darien, CT Vascular Surgery $8,450.00
Siddhartha Rao Cary, NC Interventional Cardiology $6,600.00
Shadi Halabi Munster, IN Interventional Cardiology $5,635.00
Sreekumar Madassery Chicago, IL Vascular & Interventional Radiology $5,610.00
Gloria Salazar Chapel Hill, NC Vascular & Interventional Radiology $5,500.00
Kenneth Spearman Arroyo Grande, CA Vascular & Interventional Radiology $5,070.64

Prescribed (6554) Periph Vasc Undiv?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.